Products

What will AGI do for Acetaminophen/aluminum hydroxide/aspirin/caffeine/magnesium hydr?

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN103. This VA Drug Class (CN103) classifies this compound as belonging to the group NON-OPIOID ANALGESICS. The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. The European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. The World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification. The second component of this combination drug is a common antacid with the molecular formula Al.3HO, a compound that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 5QB0T2IUN0, which is chemically known as aluminium(3+) trioxidanide but which is more generally known as aluminum hydroxide, which bears U.S. National Institutes of Health Compound Identifier 115283. The European Medicines Agency schedules aluminum hydroxide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11700MIG. The third component of this combination drug is a cyclooxygenase inhibitor with the molecular formula C9H8O4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier R16CO5Y76E, chemically known as salicylic acid, acetyl- but more generally known as acetylsalicylic acid, which bears U.S. National Institutes of Health Compound Identifier 2244. The European Medicines Agency schedules Acetylsalicylic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12730MIG. The World Health Organization schedules acetylsalicylic acid in its Anatomical Therapeutic Chemical (ATC) Classification. The fourth component of this combination drug is a cns stimulant and bioactive food component with the molecular formula C8H10N4O2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 3G6A5W338E, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears U.S. National Institutes of Health Compound Identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate. The European Medicines Agency schedules Caffeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13146MIG. The World Health Organization schedules caffeine in its Anatomical Therapeutic Chemical (ATC) Classification. The fifth component of this combination drug is an antacid with the molecular formula Mg.2HO, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier NBZ3QY004S, chemically known as magnesium ion, 2 waters coordinated but more generally known as magnesium hydroxide, which bears U.S. National Institutes of Health Compound Identifier 14791. The European Medicines Agency schedules Magnesium hydroxide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14429MIG. The World Health Organization schedules magnesium hydroxide in its Anatomical Therapeutic Chemical (ATC) Classification.